INFLAM-X PRO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Aug 2023)
What this means for you
Registered since 14 Mar 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86421508
- Registration number
- 5161521
- Mark type
- Stylized text
- Filed
- 12 Oct 2014
- Published for opposition
- 18 Aug 2015
- Registered
- 14 Mar 2017
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for topical gels and ointments for transdermal delivery of analgesics, anti-inflammatory agents, antineoplastic agents, muscle relaxants, anaesthetic agents, peptides, proteins, growth factors, hormones, substance P antagonists, antifungal compounds, antiviral compounds, antibacterial compounds, antiobesity drugs, homeopathic agents, antianginal compounds, hair growth stimulators or retardants, nutrients, and antimetabolites
Owner
- Gensco Laboratories, LLC, Doral, FL, US
- Gensco Laboratories, LLC, Doral, FL, US
- Gensco Laboratories, LLC, Doral, FL, US
Prosecution history
- 14 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 31 Aug 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Aug 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Aug 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Mar 2023 — TEAS SECTION 8 & 15 RECEIVED
- 14 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
- 08 Feb 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Feb 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Feb 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Mar 2016 — USE AMENDMENT FILED
- 15 Apr 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Apr 2016 — SOU EXTENSION 1 GRANTED
- 09 Mar 2016 — SOU EXTENSION 1 FILED
- 11 Apr 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL